Vaccine adjuvants

Seminars in Veterinary Medicine and Surgery-Small Animal

Volumn 12, Issue 3, 1997, Pages 206-211

  Macy, Dennis W ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOLOGICAL ADJUVANT; VACCINE;

ANIMAL; ANIMAL DISEASE; CHEMICALLY INDUCED DISORDER; DELAYED RELEASE FORMULATION; DRUG EFFECT; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; NEOPLASM; PHYSIOLOGY; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; DELAYED-ACTION PREPARATIONS; IMMUNE SYSTEM; IMMUNOTHERAPY; NEOPLASMS; VACCINES;

EID: 0031201667     PISSN: 08820511     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-2867(97)80034-5     Document Type: Article

References (42)

1. Ramon G: Sur l'augmentation anormale de l'antitoxine chez le chevaux producteurs de serum antidiphterique. Bull Soc Centr Med Vet 101:227, 1925
2. Allison AC, Byars NE: An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J Immunol Methods 95:157-168, 1986
3. Vanselow BA: The application of adjuvants to veterinary medicine. Vet Bull 57:881-896, 1987
4. Bomford R: The comparative selectivity of adjuvants for humoral and cell-mediated immunity. Clin Exp Immunol 39:435-441, 1980
5. Beh KJ, Lascelles AR: The effect of adjuvants and prior immunization on the rate and mode of uptake of antigen into afferent popliteal lymph from sheep. Immunology 54:487-495, 1985
6. Schroder U, Stahl A: Crystallized dextran nanospheres with entrapped antigen and their use as adjuvants. J Immunol Methods 70:127-132, 1984
7. Dresser DW, Taub RN, Krantz AR: The effect of localized injection of adjuvant material on the draining lymph node. II. Circulating lymphocytes. Immunology 18:663-670, 1970
8. Taub RN, Krantz AR, Dresser DW: The effect of localized injection of adjuvant material on the draining lymph node. Immunology 18:171-186, 1970
9. Stewart-Tull DES: Immunopotentiating conjugates. Vaccine 3:40-44, 1985
10. Waksman BH: Adjuvants and immune regulation by lymphoid cells, in Chedid L, Miescher PA, Mueller-Eberhard HJ (eds): Immunostimulation. Berlin, Springer-Verlag, 1980, pp 5-33
11. Berglund G: Preparation of anti-serum to an antigen of low-molecular weight. Nature (London) 206:523-524, 1965
12. Warren HS, Vogel FR, Chedid LA: Current status of immunological adjuvants. Annu Rev Immunol 4:369-388, 1986
13. Kennedy JW, Watson DL: Cellular basis for differences in humoral immune responses of sheep immunized with living or killed Staphylococcus aureus vaccines. Aust J Exp Biol Med Sci 60:643-654, 1982
14. Kerlin RL, Watson DL, Colditz IG: Inflammatory and immunological responses in skin and peripheral lymph of sheep following intracutaneous injection of Staphylococcus aureus. Inflammation 11:175-188, 1987
15. Freund J, Lipton MM: Experimental allergic encephalomyelitis after the excision of the injection site of antigen-adjuvant emulsion. J Immunol 75:454-460, 1955
16. Lascelles AK, Eagleson G, Beh KJ, et al: Significance of Freund's adjuvant/antigen injection granuloma in the maintenance of serum antibody response. Vet Immunol Immunopathol 22:15-27, 1989
17. Scott MT, Goss-Sampson M, Bomford R: Adjuvant activity of saponin: Antigen localization studies. Int Arch Allergy Appl Immunol 77:409-412, 1985
18. Tew JG, Phipps RP, Mendel TE: The maintenance and regulation of the humoral immune response: Persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells. Immunol Rev 53:175-201, 1980
19. McConnell I, Hopkins J, Lachmann P: Lymphocyte traffic through lymph nodes during cell shutdown, in Proter R, O'Connor M, Whelan J (eds): Blood Cells and Vessel Walls: Functional Interactions. Ciba Foundation Symposium 71 (New series). Amsterdam, Excerpta Medica 1980, pp 167-189
20. Coon J, Hunter RL: Selective induction of delayed hypersensitivity by a lipid conjugated protein antigen which is localized in thymus-dependent lymphoid tissue. J Immunol 110:183-190, 1973
21. Lanzavecchia A: Receptor-medicated antigen uptake and its effect on antigen presentation to class-II restricted T lymphocytes. Annu Rev Immunol 8:773-793, 1990
22. Kourilsky P, Claverie JM: MHC-antigen interaction: What does the T cell receptor see. Adv Immunol 45:107-193, 1989
23. Glenny AT, Pope CG, Waddington H, et al: The antigenic value of toxoid precipitated by potassium alum. J Pathol Bacteriol 29:38-39, 1926
24. Talmage DW, Dixon FJ: The influence of adjuvants on the elimination of soluble protein antigens and the associated antibody response. J Infect Dis 93:176-180, 1953
25. Lei JC: Aluminum hydroxide gel: Guidelines for adsorption. Vaccine 3:54-55, 1985
26. Freund J, Casals J, Hosmer EP: Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Proc Soc Exp Biol Med 37:509-513, 1937
27. Woodhour AF, Metzgar DP, Stim TB, et al: New metabolizable immunologic adjuvant for human use. I. Development and animal immune response. Proc Soc Exp Biol Med 116:516-523, 1964
28. Kimura J, Nariuchi H, Watanabe T, et al: Studies on the adjuvant effect of water-in-oil-in-water (w/o/w) emulsion of sesame oil. I. Enhanced and persistent antibody formation by antigen incorporated into the water-in-oil-in-water emulsion. Jpn J Exp Med 48:149-154, 1978
29. Bumford R: Adjuvants, in Spier RE, Griffiths JB (eds): Animal Cell Biotechnology. London, Oxford University Press, 1986, pp 177-194
30. Dalsgaard K: Saponin adjuvants. III. Isolation of a substance from Quilla ja saponaria Molina with adjuvant activity in foot-and-mouth disease vaccines. Arch Gesamte Viruforsch 44:243-254, 1974
31. Dalsgaard K, Hilgers L, Trouve G: Classical and new approaches to adjuvant use in domestic food animals. Adv Vet Sci Comp Med 35:121-160, 1990
32. Espinet RG: Nuevo tipa de vacuna antiaftosa a complejo glucovirico. Gac Vet 74:1-13, 1951
33. Dalsgaard K: A study of the isolation and characterization of the saponin Quil A. Acta Vet Scand Suppl 69:1-40, 1976
34. Scott MT, Bahr G, Moddaber F, et al: Adjuvant requirements for protective immunization of mice using a Trypanosoma cruzi 90 kilodalton cell surface glycoprotein. Int Arch Allergy Appl Immunol 74:373-377, 1984
35. Bumford R: The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clin Exp Immunol 39:426-434, 1980
36. Lewis PA, Loomis D: Allergic irritability: Formation and anti-sheep hemolytic amboceptor in the normal and tuberculous guinea pig. J Exp Med 40:503-515, 1924
37. Vanselow BA: The application of adjuvants to veterinary medicine. Vet Bull 57:881-896, 1987
38. Chedid L, Audibert F, Johnson AG: Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents. Prog Allergy 25:63-105, 1978
39. Nagao S, Tanaka A: Muramyl peptide-induced adjuvant arthritis. Infect Immun 28:624-626, 1980
40. Byars NE, Allison AC: Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity. Vaccine 5:223-228, 1987
41. Macy DW: The potential role and mechanisms of FeLV vaccine-induced neoplasms. Sem Vet Med Surg (Small Anm) 10:234-237, 1995
42. Macy DW, Hendrick MJ: The potential role of inflammation in the development of postvaccinal sarcomas in cats. Vet Clin North Am: Small Anim Pract 26:103-109, 1996